- Home
- NVO vs V Comparison
NVO vs V Comparison
Compare NVO & V Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | V |
|---|---|---|
| Founded | 1923 | 1958 |
| Country | Denmark | United States |
| Employees | 69500 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.5B | 676.2B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | NVO | V |
|---|---|---|
| Price | $36.86 | $300.74 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 21 |
| Target Price | $51.00 | ★ $397.43 |
| AVG Volume (30 Days) | ★ 14.1M | 6.4M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.48% | 0.89% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $21,846,000,000.00 |
| Revenue This Year | N/A | $13.81 |
| Revenue Next Year | $3.30 | $10.34 |
| P/E Ratio | ★ $13.60 | $30.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.12 | $293.89 |
| 52 Week High | $81.44 | $375.51 |
Technical Indicators
Market Signals| Indicator | NVO | V |
|---|---|---|
| Relative Strength Index (RSI) | 39.78 | 42.92 |
| Support Level | $35.85 | $297.03 |
| Resistance Level | $37.44 | $308.49 |
| Average True Range (ATR) | 0.93 | 6.36 |
| MACD | 0.43 | 0.26 |
| Stochastic Oscillator | 44.36 | 41.76 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About V Visa Inc.
Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.